Lorus therapeutics to acquire Genesense

Article Abstract:

Lorus Therapeutics Inc of Toronto, Canada, is acquiring GeneSense Technologies Inc in a stock deal designed to create a large oncology firm that could develop several cancer therapies. Lorus will issue 36 mil in new shares to finance the deal, which is priced at around $32 mil based on the stock's closing price on Apr 14, 1999. HSBC Securities Inc will be the financial adviser of the proposed deal that will give GeneSense shareholders a 30% ownership stake in Lorus.

Acquisitions & mergers, Anticancer Drugs, Antineoplastic agents, GeneSense Technologies Inc

---

Lorus Therapeutics head to step down

Article Abstract:

Markham, Ont.-based Lorus Therapeutics Inc. has announced the resignation of its chairman and chief executive officer, Philippe Lacaille. Lorus Therapeutics also announced an expansion in its cancer research operations.

Executive changes & profiles, Officials and employees, Appointments, resignations and dismissals, Lacaille, Philippe, Lorus Therapeutics Inc.

---

Celmed launched to develop cell R&D

Article Abstract:

Theratechnologies Inc. spins off its cell research unit into Celmed Biosciences Inc.

Biochemistry, Research and Development in the Physical, Engineering, and Life Sciences, Biotechnology industry, Mergers, acquisitions and divestments, Biotechnology industries, Theratechnologies Inc., Celmed Biosciences Inc.

Similar abstracts:

• Abstracts: Placer says output to rise at mine. Miners turn to Net for cost savings. Gold stocks rise amid speculation of more deals
• Abstracts: Group pushes TVX to sell stake in 5 mines. Placer to sell stake in Venezuela project. Franco-Nevada to take over Echo Bay
• Abstracts: Nortel stock sold before warning, suit claims. Quebec group launches class-action suit against Nortel. Wi-Lan launches suit
• Abstracts: Phillips puts Alberta property on block. N.S. puts oil firm on block: Will it get bids?
• Abstracts: Merger creates oil sands giant. Apache buys more of oil patch

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.